Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8763-8772
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8763
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8763
Non-recurrent group (n = 250), n (%) | Recurrent group (n = 111), n (%) | P value | |
Age (mean ± SD) | 49.57 ± 9.22 | 51.15 ± 9.67 | 0.1395 |
Sex, male | 165 (66) | 67 (60.36) | 0.3022 |
BMI (kg/m2) (mean ± SD) | 23.74 ± 3.3 | 24.3 ± 3.69 | 0.1552 |
Smoking | 0.8010 | ||
Never | 82 (40.39) | 33 (37.93) | |
Ex-smoker | 68 (33.5) | 28 (32.18) | |
Current smoker | 53 (26.11) | 26 (29.89) | |
Alcohol consumption | 0.9465 | ||
None to minimal (< 70 g/wk) | 120 (51.28) | 51 (52.58) | |
Moderate (70-279 g/wk) | 82 (35.04) | 34 (35.05) | |
Heavy (> 280 g/wk) | 32 (13.68) | 12 (12.37) | |
Medication1 | 8 (3.4) | 3 (3.09) | 1.000 |
HTN (Yes) | 54 (21.6) | 30 (27.03) | 0.2601 |
DM (Yes) | 19 (7.6) | 6 (5.41) | 0.4485 |
Hyperlipidemia | 56 (22.4) | 29 (26.13) | 0.4413 |
- Citation: Jin EH, Song JH, Lee J, Bae JH, Chung SJ. Midazolam dose is associated with recurrence of paradoxical reactions during endoscopy. World J Clin Cases 2021; 9(29): 8763-8772
- URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8763.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8763